EMA Recommends Extension of Indications for Atezolizumab
New indications concern the first-line treatment of patients with metastatic non-squamous NSCLC who do not have EGFR mutated or ALK positive tumours,and those with extensive-stage SCLC
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
New indications concern the first-line treatment of patients with metastatic non-squamous NSCLC who do not have EGFR mutated or ALK positive tumours,and those with extensive-stage SCLC
First ‘histology-independent’ treatment in the EU for solid tumours with a NTRK gene fusion
Greatest absolute benefit found in patients with stage III endometrial cancer or serous histology, or both
The results from KEYNOTE-183 study in patients with relapsed or refractory multiple myeloma
It was intended for the treatment of sickle cell disease
Identification of risk loci and a polygenic risk score for lung cancer in a large-scale prospective cohort study in Chinese populations
Results from a transcriptome-wide association study in over 140,000 European descendants
Collecting data for better representation of genetic variability
Recent study in France suggested that the risk of meningioma, although very low, may be increased when taking high doses of cyproterone for a long period
Results from a randomised trial in preventing herpes zoster in immunocompromised patients after autologous haematopoietic stem cell transplantation
Approval is based on efficacy and safety results from Part 2 of the STORM study
KLHL11 identified as anovel paraneoplastic autoantibody
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.